Immunome, Inc.
IMNM
$18.08
-$0.32-1.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.30% | 12.90% | -21.99% | -20.14% | 67.84% |
| Total Depreciation and Amortization | 3.72% | 30.42% | 28.37% | 6.98% | 176.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.42% | -44.44% | -41.92% | -45.22% | -95.70% |
| Change in Net Operating Assets | 20.22% | -39.05% | 361.91% | -510.37% | -479.71% |
| Cash from Operations | -10.52% | -14.01% | -18.56% | -111.14% | -374.98% |
| Capital Expenditure | 18.09% | -255.15% | 27.49% | 61.39% | -69.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -202.97% | -100.00% | 387.58% | 20.26% | 124.96% |
| Cash from Investing | -336.12% | -140.98% | 414.08% | 21.44% | 113.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.87% | 2,148.36% | 8,997.84% | -81.51% | -26.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.53% | -6,845.50% | -350.49% | 42.43% | 25.93% |
| Cash from Financing | -100.08% | 2,054.82% | 14,781.64% | -107.93% | -26.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.95% | 3,217.32% | 1,418.75% | -8.85% | -33.20% |